Mark Bruss, MD
Family Medicine · Waterville, OHNPI 1720082423
Payments from drug & device makers
Across 98 payments — averaging $16.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$222
- Pfizer$136
- Boehringer Ingelheim$133
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$84
- Novo Nordisk$72
- Amarin Pharma, Inc.$72
- plus $876 from 27 others
What the payments were for
- Food & beverage$1,58199%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 12 | $222 |
| Pfizer | 9 | $136 |
| Boehringer Ingelheim | 7 | $133 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $84 |
| Novo Nordisk | 5 | $72 |
| Amarin Pharma, Inc. | 4 | $72 |
| Exact Sciences | 4 | $68 |
| UCB, Inc. | 3 | $65 |
| Amgen | 4 | $62 |
| AstraZeneca | 5 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $58 |
| Novartis | 3 | $51 |
| GSK | 3 | $47 |
| Astellas Pharma US Inc | 3 | $47 |
| Sanofi-aventis U.S. LLC | 3 | $44 |
| Bayer | 2 | $38 |
| Eisai Inc. | 2 | $34 |
| Merck | 2 | $31 |
| Johnson & Johnson | 2 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Lilly USA, LLC | 2 | $25 |
| Lundbeck LLC | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Shield Therapeutics Inc | 1 | $18 |
| VBI Vaccine (delaware) Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| Bausch Health US, LLC | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Glenmark Therapeutics Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Corium, LLC | 1 | $12 |
How this compares
$1,595 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 302 | $236,308 |
| OzempicSemaglutide | 47 | $67,590 |
| FarxigaDapagliflozin Propanediol | 40 | $49,640 |
| JanuviaSitagliptin Phosphate | 39 | $46,807 |
| JardianceEmpagliflozin | 43 | $44,388 |
| XareltoRivaroxaban | 51 | $44,176 |
| ProliaDenosumab | 23 | $41,952 |
| LinzessLinaclotide | 45 | $25,654 |
| EntrestoSacubitril/Valsartan | 21 | $20,597 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 67 | $14,161 |
| MyrbetriqMirabegron | 16 | $10,438 |
| Tresiba Flextouch U-100Insulin Degludec | 14 | $10,194 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 21 | $9,789 |
| Breo ElliptaFluticasone/Vilanterol | 17 | $7,548 |
| Esomeprazole Magnesium | 40 | $6,659 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Paxlovid | $136 | $240,579326 claims |
| Novo NordiskOzempic | $72 | $67,59047 claims |
| AstraZenecaFarxiga | $61 | $49,64040 claims |
| MerckJanuvia | $31 | $46,80739 claims |
| Boehringer IngelheimJardiance | $133 | $44,38843 claims |
| Johnson & JohnsonXarelto | $27 | $44,17651 claims |
| AmgenProlia | $62 | $41,95223 claims |
| AbbVieLinzess | $222 | $25,65445 claims |
| GSKShingrix, Breo Ellipta | $47 | $21,71084 claims |
| NovartisEntresto | $51 | $20,59721 claims |
| Astellas Pharma US IncMyrbetriq | $47 | $10,43816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Waterville
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.